RT @NoufAhmedAlham2: Belimumab in Active lupus nephritis , Ken Kalunian #RNL2023 â¦@RheumNowâ© https://t.co/VZkmK8Iny7
Tweet Content
Belimumab in Active lupus nephritis , Ken Kalunian #RNL2023 @RheumNow https://t.co/VZkmK8Iny7
Carpal Tunnel - Steroid injection vs. Night Splinting A randomized trial conducted by the UK National Health Service,
Tweet Content
Carpal Tunnel - Steroid injection vs. Night Splinting
A randomized trial conducted by the UK National Health Service, studied interventions in patients with CTS and found no advantage to either CTS CSIor NS as the initial treatment of CTS.
https://t.co/dcE2P6RqoC https://t.co/pykkXs8qqi
Links
RT @NoufAhmedAlham2: Risk of adverse outcomes in PsA pregnancies More pre eclampsia More Cesarian section More preter
Tweet Content
Risk of adverse outcomes in PsA pregnancies
More pre eclampsia
More Cesarian section
More preterms
By Dr.Chambers #RNL2023 @RheumNow https://t.co/LRiSSpv4Yj
RT @gurdeep_dulay: Smoking *may* only â¬ï¸ risk of #RA if shared epitope present AND double positive By @Janetbirdop
Tweet Content
Smoking *may* only ⬆️ risk of #RA if shared epitope present AND double positive
By @Janetbirdope #RNL2023 https://t.co/TG1hseVCsD
RT @ericdeinmd: #RNL2023 Year in Review @andreafava: urinary biomarkers in lupus nephritis CD163, IL-16, CD206 decrease
Tweet Content
#RNL2023 Year in Review
@andreafava: urinary biomarkers in lupus nephritis
CD163, IL-16, CD206 decrease at 3 months.
Urinary biomarkers predict 1 year proteinuric response, esp in prolif LN.
Liquid biopsy as way to monitor instead of serial biopsies
@RheumNow https://t.co/baZt57Qjne
RT @doctorRBC: Dr. Eric Ruderman with an excellent review of the JAK/STAT pathway especially for PsA treatment @RheumNow
Tweet Content
Dr. Eric Ruderman with an excellent review of the JAK/STAT pathway especially for PsA treatment
@RheumNow #RNL2023 https://t.co/kNDouZ4kCV
RT @ericdeinmd: #RNL2023 Year in Review HCQ levels in SLE >500 ng/mL = 19x higher adherence >750 ng/mL 67% lower o
Tweet Content
#RNL2023 Year in Review
HCQ levels in SLE
>500 ng/mL = 19x higher adherence
>750 ng/mL 67% lower odds of adherence
Higher levels with CKD
I use HCQ levels in all patients for monitoring at each visit
@RheumNow https://t.co/6yCefQdPU0
RT @ericdeinmd: #RNL2023 Year in Review COMPLETE-PsA: DMARDs for PsA! LEF+MTX better than MTX alone, 78 total patients P
Tweet Content
#RNL2023 Year in Review
COMPLETE-PsA: DMARDs for PsA!
LEF+MTX better than MTX alone, 78 total patients
PASDAS at week 16: 59% for MTX+LEF vs 34% MTX+PBO
More treatment discontinuations (10 vs 3) in combo group due to GI intolerance
@RheumNow https://t.co/3Al8PQmNli
RT @NoufAhmedAlham2: PMR classification criteria by â¦@anisha_duaâ© â¦@RheumNowâ© #RNL2023 Bursal and biceps tenos
Tweet Content
PMR classification criteria by @anisha_dua @RheumNow #RNL2023
Bursal and biceps tenosynovitis gets one point in PMR classification criteria. https://t.co/Lj1X9mkgBz
RT @uptoTate: Check out MothertoBaby fact sheets by the NIH and LactRX (by mother to baby) app for pregnancy, disease, a
Tweet Content
Check out MothertoBaby fact sheets by the NIH and LactRX (by mother to baby) app for pregnancy, disease, and medications. Dr. C. Chambers highlighted this today at #RNL2023 @RheumNow
